Alliance of the "Mor[e]s"
This article was originally published in The Tan Sheet
Executive Summary
Online H&BA retailer More.com and discount drug chain Phar-Mor are joining forces to offer consumers an expanded "click and mortar" shopping site. The agreement will add several features to more.com's existing H&BA offerings, including contact lenses and an online Rx drug service with same-day pick-up at Phar-Mor's 139 independent drug stores. A new URL will be launched "later this spring." The new site will be promoted through in-store marketing efforts at Phar-Mor locations and an advertising campaign in selected regions. The alliance follows several other similar arrangements between e-tailers and Rx drug stores or health plans, including drugstore.com/Rite Aid, CVS.com/Merck-Medco and PlanetRx.com/Express Scripts
You may also be interested in...
More.com Retooling, Expansion Planned For Estimated IPO Proceeds
More.com's proposed maximum aggregate offering price is $86.3 mil. for its upcoming initial public offering, the online retailer says in a preliminary registration statement filed with the Securities & Exchange Commission Feb. 11. The price is estimated because the firm has not specified the number of shares or per-share price in the filing.
More.com Retooling, Expansion Planned For Estimated IPO Proceeds
More.com's proposed maximum aggregate offering price is $86.3 mil. for its upcoming initial public offering, the online retailer says in a preliminary registration statement filed with the Securities & Exchange Commission Feb. 11. The price is estimated because the firm has not specified the number of shares or per-share price in the filing.
More.com Retooling, Expansion Planned For Estimated IPO Proceeds
More.com's proposed maximum aggregate offering price is $86.3 mil. for its upcoming initial public offering, the online retailer says in a preliminary registration statement filed with the Securities & Exchange Commission Feb. 11. The price is estimated because the firm has not specified the number of shares or per-share price in the filing.